Loading...
OTCM
ZHJLF
Market cap816mUSD
, Last price  
USD
Name

Zhong Ji Longevity Science Group Ltd

Chart & Performance

D1W1MN
OTCM:ZHJLF chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-16.68%
Rev. gr., 5y
15.20%
Revenues
165m
-2.04%
1,190,589,9261,029,039,556733,979,076391,230,2934,373,88352,958,00034,720,00029,693,00064,239,000102,391,000555,386,000273,347,000180,048,000147,432,00081,407,00062,982,00089,445,00064,989,000168,626,000165,180,000
Net income
-17m
L-51.76%
3,561,6379,887,7870075,998,163-134,081,00062,283,00075,597,000-26,008,000-148,282,000321,907,00082,274,000-2,199,094,000-825,678,000-11,487,0006,055,000-904,0002,313,000-34,726,000-16,751,000
CFO
-23m
L-62.13%
44,753,75720,329,22910,989,61300-369,357,000222,736,000-98,372,000-127,606,000-88,516,00045,744,000-107,598,000214,190,000-2,527,000-191,537,000-39,617,00012,108,00015,728,000-61,054,000-23,119,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China. The company's healthcare division delivers diagnostic advisory services, medical examination and testing, and the supply of health-related supplements. Furthermore, Zhong Ji Longevity is involved in holding equity stakes, investing in both short and long-term financial instruments, offering financial and investment advisory, and property acquisition. It also extends health advisory services and deals in medical commodities. Founded in 1994, the company was formerly known as Asia Pacific Silk Road Investment Company Limited before rebranding to its current name in March 2021. Its main office is situated in Causeway Bay, Hong Kong.
URL
IPO date
Nov 20, 1995
Employees
33
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT